{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T18:52:11Z","timestamp":1793213531679,"version":"4.5.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.taap.2026.117921","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T07:16:49Z","timestamp":1782199009000},"page":"117921","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Salidroside suppresses hypoxia-induced ocular angiogenesis by modulating the acetylation of PFKFB3 protein in endothelial cells and regulating glycolytic activity"],"prefix":"10.1016","volume":"514","author":[{"given":"Na","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuling","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonghe","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyan","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yage","family":"Yun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dayong","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.taap.2026.117921_bb0005","first-page":"3239","article-title":"A rapid in vitro assay for quantitating the invasive potential of tumor cells","volume":"47","author":"Albini","year":"1987","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.taap.2026.117921_bb0010","article-title":"FOXC1 regulates endothelial CD98 (LAT1\/4F2hc) expression in retinal angiogenesis and blood-retina barrier formation","volume":"15","author":"Bhakuni","year":"2024"},{"issue":"15","key":"10.1016\/j.taap.2026.117921_bb0015","article-title":"Epigallocatechin-3-gallate, an active green tea component to support anti-VEGFA therapy in wet age-related macular degeneration","volume":"15","author":"Blasiak","year":"2023"},{"issue":"1","key":"10.1016\/j.taap.2026.117921_bb0020","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s13046-022-02252-1","article-title":"TRPM7 silencing modulates glucose metabolic reprogramming to inhibit the growth of ovarian cancer by enhancing AMPK activation to promote HIF-1\u03b1 degradation","volume":"41","author":"Chen","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"W1","key":"10.1016\/j.taap.2026.117921_bb0025","doi-asserted-by":"crossref","first-page":"W357","DOI":"10.1093\/nar\/gkz382","article-title":"SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules","volume":"47","author":"Daina","year":"2019","journal-title":"Nucleic Acids Res."},{"issue":"3","key":"10.1016\/j.taap.2026.117921_bb0030","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.cell.2013.06.037","article-title":"Role of PFKFB3-driven glycolysis in vessel sprouting","volume":"154","author":"De Bock","year":"2013","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.taap.2026.117921_bb0035","article-title":"The PFKFB3 inhibitor AZ67 inhibits angiogenesis independently of glycolysis inhibition","volume":"22","author":"Emini Veseli","year":"2021"},{"issue":"12","key":"10.1016\/j.taap.2026.117921_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.105526","article-title":"Survivin promotes a glycolytic switch in CD4(+) T cells by suppressing the transcription of PFKFB3 in rheumatoid arthritis","volume":"25","author":"Erlandsson","year":"2022","journal-title":"iScience"},{"issue":"9","key":"10.1016\/j.taap.2026.117921_bb0045","doi-asserted-by":"crossref","DOI":"10.7150\/thno.96946","article-title":"Targeting endothelial glycolytic reprogramming by tsRNA-1599 for ocular anti-angiogenesis therapy","volume":"14","author":"Han","year":"2024","journal-title":"Theranostics"},{"issue":"19","key":"10.1016\/j.taap.2026.117921_bb0050","doi-asserted-by":"crossref","DOI":"10.3390\/ijms221910279","article-title":"Inhibition of APE1\/Ref-1 for neovascular eye diseases: from biology to therapy","volume":"22","author":"Hartman","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.taap.2026.117921_bb0055","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1248\/bpb.19.1518","article-title":"A combined assay of cell viability and in vitro cytotoxicity with a highly water-soluble tetrazolium salt, neutral red and crystal violet","volume":"19","author":"Ishiyama","year":"1996","journal-title":"Biol. Pharm. Bull."},{"issue":"9","key":"10.1016\/j.taap.2026.117921_bb0060","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1038\/nprot.2014.138","article-title":"The cellular thermal shift assay for evaluating drug target interactions in cells","volume":"9","author":"Jafari","year":"2014","journal-title":"Nat. Protoc."},{"issue":"4","key":"10.1016\/j.taap.2026.117921_bb0065","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.molcel.2006.06.026","article-title":"Substrate and functional diversity of lysine acetylation revealed by a proteomics survey","volume":"23","author":"Kim","year":"2006","journal-title":"Mol. Cell"},{"issue":"D1","key":"10.1016\/j.taap.2026.117921_bb0070","doi-asserted-by":"crossref","first-page":"D1373","DOI":"10.1093\/nar\/gkac956","article-title":"PubChem 2023 update","volume":"51","author":"Kim","year":"2023","journal-title":"Nucleic Acids Res."},{"issue":"2","key":"10.1016\/j.taap.2026.117921_bb0075","article-title":"O-GlcNAcylation of PFKFB3 is required for tumor cell proliferation under hypoxia","volume":"9","author":"Lei","year":"2020"},{"issue":"1","key":"10.1016\/j.taap.2026.117921_bb0080","article-title":"Acetylation accumulates PFKFB3 in cytoplasm to promote glycolysis and protects cells from cisplatin-induced apoptosis","volume":"9","author":"Li","year":"2018"},{"issue":"7","key":"10.1016\/j.taap.2026.117921_bb0085","doi-asserted-by":"crossref","DOI":"10.3390\/cells8070752","article-title":"Dual roles of the AMP-activated protein kinase pathway in angiogenesis","volume":"8","author":"Li","year":"2019","journal-title":"Cells"},{"issue":"Pt A","key":"10.1016\/j.taap.2026.117921_bb0090","article-title":"Rhodiola tangutica (maxim.) S. H. Fu protects blood-retinal barrier in hypoxia-induced retinal injury rats by down-regulating HIF-1\u03b1\/eNOS\/NO pathway","volume":"353","author":"Li","year":"2025","journal-title":"J. Ethnopharmacol."},{"issue":"Web Server issue","key":"10.1016\/j.taap.2026.117921_bb0095","doi-asserted-by":"crossref","first-page":"W609","DOI":"10.1093\/nar\/gkq300","article-title":"PharmMapper server: a web server for potential drug target identification using pharmacophore mapping approach","volume":"38","author":"Liu","year":"2010","journal-title":"Nucleic Acids Res."},{"issue":"22","key":"10.1016\/j.taap.2026.117921_bb0100","first-page":"5109","article-title":"Suppression of myeloid PFKFB3-driven glycolysis protects mice from choroidal neovascularization","volume":"179","author":"Liu","year":"2022"},{"key":"10.1016\/j.taap.2026.117921_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2020.100906","article-title":"Incomplete response to anti-VEGF therapy in neovascular AMD: exploring disease mechanisms and therapeutic opportunities","volume":"82","author":"Mettu","year":"2021","journal-title":"Prog. Retin. Eye Res."},{"issue":"1","key":"10.1016\/j.taap.2026.117921_bb0110","first-page":"178","article-title":"Therapeutic targeting of PFKFB3 with a novel glycolytic inhibitor PFK158 promotes lipophagy and chemosensitivity in gynecologic cancers","volume":"144","author":"Mondal","year":"2019"},{"issue":"8","key":"10.1016\/j.taap.2026.117921_bb0115","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.7150\/thno.81714","article-title":"Therapeutic effect of ultra-long-lasting human C-peptide delivery against hyperglycemia-induced neovascularization in diabetic retinopathy","volume":"13","author":"Moon","year":"2023","journal-title":"Theranostics"},{"key":"10.1016\/j.taap.2026.117921_bb0120","doi-asserted-by":"crossref","DOI":"10.1093\/database\/baq020","article-title":"GeneCards version 3: the human gene integrator","volume":"2010","author":"Safran","year":"2010","journal-title":"Database (Oxford)"},{"issue":"7","key":"10.1016\/j.taap.2026.117921_bb0125","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH image to ImageJ: 25 years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.taap.2026.117921_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114714","article-title":"Triciribine attenuates pathological neovascularization and vascular permeability in a mouse model of proliferative retinopathy","volume":"162","author":"Shan","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.taap.2026.117921_bb0135","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ymeth.2014.08.016","article-title":"Multiplexed immunohistochemistry, imaging, and quantitation: a review, with an assessment of Tyramide signal amplification, multispectral imaging and multiplex analysis","volume":"70","author":"Stack","year":"2014","journal-title":"Methods"},{"issue":"9","key":"10.1016\/j.taap.2026.117921_bb0140","doi-asserted-by":"crossref","first-page":"4350","DOI":"10.1073\/pnas.76.9.4350","article-title":"Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications","volume":"76","author":"Towbin","year":"1979","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.taap.2026.117921_bb0145","article-title":"Mechanistic insights into Salidroside\u2019s mitochondrial protection via AMPK\/Sirt1\/HIF-1\u03b1 pathway in hypoxic HT22 cells","volume":"218","author":"Wang","year":"2025","journal-title":"J. Visual. Exp."},{"key":"10.1016\/j.taap.2026.117921_bb0150","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.trsl.2022.10.001","article-title":"PFKFB3 mediates tubular cell death in cisplatin nephrotoxicity by activating CDK4","volume":"253","author":"Wen","year":"2023","journal-title":"Transl. Res."},{"issue":"3","key":"10.1016\/j.taap.2026.117921_bb0155","first-page":"789","article-title":"Sensitive blood-retinal barrier breakdown quantitation using Evans blue","volume":"42","author":"Xu","year":"2001","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"1","key":"10.1016\/j.taap.2026.117921_bb0160","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1080\/13880209.2021.1992449","article-title":"Salidroside orchestrates metabolic reprogramming by regulating the Hif-1\u03b1 signalling pathway in acute mountain sickness","volume":"59","author":"Yan","year":"2021","journal-title":"Pharm. Biol."},{"issue":"1","key":"10.1016\/j.taap.2026.117921_bb0165","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s12967-023-03932-y","article-title":"Blockage of glycolysis by targeting PFKFB3 suppresses the development of infantile hemangioma","volume":"21","author":"Yang","year":"2023","journal-title":"J. Transl. Med."},{"issue":"1","key":"10.1016\/j.taap.2026.117921_bb0170","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s40001-023-01578-6","article-title":"Salidroside protects RGC from pyroptosis in diabetes-induced retinopathy associated with NLRP3, NFEZL2 and NGKB1, revealed by network pharmacology analysis and experimental validation","volume":"29","author":"Zhang","year":"2024","journal-title":"Eur. J. Med. Res."},{"issue":"11","key":"10.1016\/j.taap.2026.117921_bb0175","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1167\/iovs.66.11.76","article-title":"PFKFB3-mediated glycolytic metabolic reprogramming regulates inflammatory response in dry eye disease","volume":"66","author":"Zhang","year":"2025","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"15","key":"10.1016\/j.taap.2026.117921_bb0180","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1167\/iovs.66.15.23","article-title":"Conformational dynamics of PKM2 regulate hypoxia-induced pathological retinal angiogenesis","volume":"66","author":"Zhu","year":"2025","journal-title":"Invest. Ophthalmol. Vis. Sci."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X26002176?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X26002176?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T06:20:07Z","timestamp":1785910807000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X26002176"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":36,"alternative-id":["S0041008X26002176"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2026.117921","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Salidroside suppresses hypoxia-induced ocular angiogenesis by modulating the acetylation of PFKFB3 protein in endothelial cells and regulating glycolytic activity","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2026.117921","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"117921"}}